Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients
{{output}}
Dyslipaemia is one of the main risk factors in the development of cardiovascular diseases. Currently, there are different alternatives available (amongst which statins occupy a pre-eminent place), to optimise the treatment of patients at high or very high card... ...
